血液スクリーニングの世界市場 2023-2027

血液スクリーニング市場は2022-2027年に11億7,602万米ドル、予測期間中のCAGRは7.42％で成長すると予測されています。

当レポートでは、血液スクリーニング市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。輸血ニーズの増加、ベンダー間の合併・買収、医療の進歩などが市場を牽引しています。

本調査では、血液スクリーニングプロセスの自動化が、今後数年間の血液スクリーニング市場成長を牽引する主要因の1つであるとしています。また、血液感染症や疾患に対する意識の高まり、ポイントオブケア検査の増加も市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 血液スクリーニングの世界市場 2017-2021
• コンポーネントセグメント分析 2017-2021
• エンドユーザーセグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：コンポーネント別

• 市場セグメント
• 比較：コンポーネント別
• 試薬とキット：市場規模と予測 2022-2027
• 機器：市場規模と予測 2022-2027
• ソフトウェアとサービス：市場規模と予測 2022-2027
• 市場機会：コンポーネント別

第7章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 血液バンク：市場規模と予測 2022-2027
• 病院：市場規模と予測 2022-2027
• 市場機会：エンドユーザー別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• BCAL Diagnostics Ltd.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• Dr Lal PathLabs Ltd.
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• Grifols SA
• Harley Street Health Checks UK Ltd.
• Hemogenomics Pvt. Ltd.
• Laboratory Corp. of America Holdings
• QuidelOrtho Corp.
• Siemens Healthineers AG
• Syantra Inc.
• Thermo Fisher Scientific Inc.
• Vijaya Diagnostic Centre Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Component
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global blood screening market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Component Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Component - Market share 2022-2027 (%)
• Exhibits31: Data Table on Component - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Component
• Exhibits33: Data Table on Comparison by Component
• Exhibits34: Chart on Reagents and kits - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Reagents and kits - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Reagents and kits - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Reagents and kits - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Software and services - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Software and services - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Software and services - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Software and services - Year-over-year growth 2022-2027 (%)
• Exhibits46: Market opportunity by Component ($ million)
• Exhibits47: Data Table on Market opportunity by Component ($ million)
• Exhibits48: Chart on End-user - Market share 2022-2027 (%)
• Exhibits49: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits50: Chart on Comparison by End-user
• Exhibits51: Data Table on Comparison by End-user
• Exhibits52: Chart on Blood bank - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Blood bank - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Blood bank - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Blood bank - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits60: Market opportunity by End-user ($ million)
• Exhibits61: Data Table on Market opportunity by End-user ($ million)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ million)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits105: Impact of drivers and challenges in 2022 and 2027
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: BCAL Diagnostics Ltd. - Overview
• Exhibits112: BCAL Diagnostics Ltd. - Product / Service
• Exhibits113: BCAL Diagnostics Ltd. - Key offerings
• Exhibits114: Becton Dickinson and Co. - Overview
• Exhibits115: Becton Dickinson and Co. - Business segments
• Exhibits116: Becton Dickinson and Co. - Key news
• Exhibits117: Becton Dickinson and Co. - Key offerings
• Exhibits118: Becton Dickinson and Co. - Segment focus
• Exhibits119: Bio Rad Laboratories Inc. - Overview
• Exhibits120: Bio Rad Laboratories Inc. - Business segments
• Exhibits121: Bio Rad Laboratories Inc. - Key news
• Exhibits122: Bio Rad Laboratories Inc. - Key offerings
• Exhibits123: Bio Rad Laboratories Inc. - Segment focus
• Exhibits124: Dr Lal PathLabs Ltd. - Overview
• Exhibits125: Dr Lal PathLabs Ltd. - Product / Service
• Exhibits126: Dr Lal PathLabs Ltd. - Key offerings
• Exhibits127: Eurofins Scientific SE - Overview
• Exhibits128: Eurofins Scientific SE - Business segments
• Exhibits129: Eurofins Scientific SE - Key news
• Exhibits130: Eurofins Scientific SE - Key offerings
• Exhibits131: Eurofins Scientific SE - Segment focus
• Exhibits132: F. Hoffmann La Roche Ltd. - Overview
• Exhibits133: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits134: F. Hoffmann La Roche Ltd. - Key news
• Exhibits135: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits136: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits137: Grifols SA - Overview
• Exhibits138: Grifols SA - Business segments
• Exhibits139: Grifols SA - Key offerings
• Exhibits140: Grifols SA - Segment focus
• Exhibits141: Harley Street Health Checks UK Ltd. - Overview
• Exhibits142: Harley Street Health Checks UK Ltd. - Product / Service
• Exhibits143: Harley Street Health Checks UK Ltd. - Key offerings
• Exhibits144: Hemogenomics Pvt. Ltd. - Overview
• Exhibits145: Hemogenomics Pvt. Ltd. - Product / Service
• Exhibits146: Hemogenomics Pvt. Ltd. - Key offerings
• Exhibits147: Laboratory Corp. of America Holdings - Overview
• Exhibits148: Laboratory Corp. of America Holdings - Business segments
• Exhibits149: Laboratory Corp. of America Holdings - Key news
• Exhibits150: Laboratory Corp. of America Holdings - Key offerings
• Exhibits151: Laboratory Corp. of America Holdings - Segment focus
• Exhibits152: QuidelOrtho Corp. - Overview
• Exhibits153: QuidelOrtho Corp. - Product / Service
• Exhibits154: QuidelOrtho Corp. - Key offerings
• Exhibits155: Siemens Healthineers AG - Overview
• Exhibits156: Siemens Healthineers AG - Business segments
• Exhibits157: Siemens Healthineers AG - Key news
• Exhibits158: Siemens Healthineers AG - Key offerings
• Exhibits159: Siemens Healthineers AG - Segment focus
• Exhibits160: Syantra Inc. - Overview
• Exhibits161: Syantra Inc. - Product / Service
• Exhibits162: Syantra Inc. - Key offerings
• Exhibits163: Thermo Fisher Scientific Inc. - Overview
• Exhibits164: Thermo Fisher Scientific Inc. - Business segments
• Exhibits165: Thermo Fisher Scientific Inc. - Key news
• Exhibits166: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits167: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits168: Vijaya Diagnostic Centre Ltd. - Overview
• Exhibits169: Vijaya Diagnostic Centre Ltd. - Business segments
• Exhibits170: Vijaya Diagnostic Centre Ltd. - Key offerings
• Exhibits171: Vijaya Diagnostic Centre Ltd. - Segment focus
• Exhibits172: Inclusions checklist
• Exhibits173: Exclusions checklist
• Exhibits174: Currency conversion rates for US$
• Exhibits175: Research methodology
• Exhibits176: Validation techniques employed for market sizing
• Exhibits177: Information sources
• Exhibits178: List of abbreviations

The blood screening market is forecasted to grow by USD 1,176.02 mn during 2022-2027, accelerating at a CAGR of 7.42% during the forecast period. The report on the blood screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing blood transfusion needs, mergers and acquisitions among vendors, and advancements in medical treatments.

Technavio's blood screening market is segmented as below:

By Component

• Reagents and kits
• Instruments
• Software and services

By End-user

• Blood bank
• Hospitals

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the automation in blood screening process as one of the prime reasons driving the blood screening market growth during the next few years. Also, increased awareness of bloodborne infections and diseases and increasing point-of-care testing will lead to sizable demand in the market.

The report on the blood screening market covers the following areas:

• Blood screening market sizing
• Blood screening market forecast
• Blood screening market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood screening market vendors that include Apollo Hospitals Enterprise Ltd., Aster Clinical Lab LLP, BCAL Diagnostics Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Dr Lal PathLabs Ltd., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Grifols SA, Harley Street Health Checks UK Ltd., Hemogenomics Pvt. Ltd., Laboratory Corp. of America Holdings, Mankind Pharma Ltd., Metropolis Healthcare Ltd., QuidelOrtho Corp., Siemens Healthineers AG, Syantra Inc., Thermo Fisher Scientific Inc., and Vijaya Diagnostic Centre Ltd.. Also, the blood screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Component
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global blood screening market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global blood screening market 2017 - 2021 ($ million)
• 4.2 Component Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Component Segment 2017 - 2021 ($ million)
• 4.3 End-user Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Component

• 6.1 Market segments
• Exhibit 30: Chart on Component - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Component - Market share 2022-2027 (%)
• 6.2 Comparison by Component
• Exhibit 32: Chart on Comparison by Component
• Exhibit 33: Data Table on Comparison by Component
• 6.3 Reagents and kits - Market size and forecast 2022-2027
• Exhibit 34: Chart on Reagents and kits - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Reagents and kits - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Reagents and kits - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Reagents and kits - Year-over-year growth 2022-2027 (%)
• 6.4 Instruments - Market size and forecast 2022-2027
• Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
• 6.5 Software and services - Market size and forecast 2022-2027
• Exhibit 42: Chart on Software and services - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Software and services - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Software and services - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Software and services - Year-over-year growth 2022-2027 (%)
• 6.6 Market opportunity by Component
• Exhibit 46: Market opportunity by Component ($ million)
• Exhibit 47: Data Table on Market opportunity by Component ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 48: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 49: Data Table on End-user - Market share 2022-2027 (%)
• 7.2 Comparison by End-user
• Exhibit 50: Chart on Comparison by End-user
• Exhibit 51: Data Table on Comparison by End-user
• 7.3 Blood bank - Market size and forecast 2022-2027
• Exhibit 52: Chart on Blood bank - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Blood bank - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Blood bank - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Blood bank - Year-over-year growth 2022-2027 (%)
• 7.4 Hospitals - Market size and forecast 2022-2027
• Exhibit 56: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by End-user
• Exhibit 60: Market opportunity by End-user ($ million)
• Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 China - Market size and forecast 2022-2027
• Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 Canada - Market size and forecast 2022-2027
• Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 BCAL Diagnostics Ltd.
• Exhibit 111: BCAL Diagnostics Ltd. - Overview
• Exhibit 112: BCAL Diagnostics Ltd. - Product / Service
• Exhibit 113: BCAL Diagnostics Ltd. - Key offerings
• 12.4 Becton Dickinson and Co.
• Exhibit 114: Becton Dickinson and Co. - Overview
• Exhibit 115: Becton Dickinson and Co. - Business segments
• Exhibit 116: Becton Dickinson and Co. - Key news
• Exhibit 117: Becton Dickinson and Co. - Key offerings
• Exhibit 118: Becton Dickinson and Co. - Segment focus
• 12.5 Bio Rad Laboratories Inc.
• Exhibit 119: Bio Rad Laboratories Inc. - Overview
• Exhibit 120: Bio Rad Laboratories Inc. - Business segments
• Exhibit 121: Bio Rad Laboratories Inc. - Key news
• Exhibit 122: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 123: Bio Rad Laboratories Inc. - Segment focus
• 12.6 Dr Lal PathLabs Ltd.
• Exhibit 124: Dr Lal PathLabs Ltd. - Overview
• Exhibit 125: Dr Lal PathLabs Ltd. - Product / Service
• Exhibit 126: Dr Lal PathLabs Ltd. - Key offerings
• 12.7 Eurofins Scientific SE
• Exhibit 127: Eurofins Scientific SE - Overview
• Exhibit 128: Eurofins Scientific SE - Business segments
• Exhibit 129: Eurofins Scientific SE - Key news
• Exhibit 130: Eurofins Scientific SE - Key offerings
• Exhibit 131: Eurofins Scientific SE - Segment focus
• 12.8 F. Hoffmann La Roche Ltd.
• Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus
• 12.9 Grifols SA
• Exhibit 137: Grifols SA - Overview
• Exhibit 138: Grifols SA - Business segments
• Exhibit 139: Grifols SA - Key offerings
• Exhibit 140: Grifols SA - Segment focus
• 12.10 Harley Street Health Checks UK Ltd.
• Exhibit 141: Harley Street Health Checks UK Ltd. - Overview
• Exhibit 142: Harley Street Health Checks UK Ltd. - Product / Service
• Exhibit 143: Harley Street Health Checks UK Ltd. - Key offerings
• 12.11 Hemogenomics Pvt. Ltd.
• Exhibit 144: Hemogenomics Pvt. Ltd. - Overview
• Exhibit 145: Hemogenomics Pvt. Ltd. - Product / Service
• Exhibit 146: Hemogenomics Pvt. Ltd. - Key offerings
• 12.12 Laboratory Corp. of America Holdings
• Exhibit 147: Laboratory Corp. of America Holdings - Overview
• Exhibit 148: Laboratory Corp. of America Holdings - Business segments
• Exhibit 149: Laboratory Corp. of America Holdings - Key news
• Exhibit 150: Laboratory Corp. of America Holdings - Key offerings
• Exhibit 151: Laboratory Corp. of America Holdings - Segment focus
• 12.13 QuidelOrtho Corp.
• Exhibit 152: QuidelOrtho Corp. - Overview
• Exhibit 153: QuidelOrtho Corp. - Product / Service
• Exhibit 154: QuidelOrtho Corp. - Key offerings
• 12.14 Siemens Healthineers AG
• Exhibit 155: Siemens Healthineers AG - Overview
• Exhibit 156: Siemens Healthineers AG - Business segments
• Exhibit 157: Siemens Healthineers AG - Key news
• Exhibit 158: Siemens Healthineers AG - Key offerings
• Exhibit 159: Siemens Healthineers AG - Segment focus
• 12.15 Syantra Inc.
• Exhibit 160: Syantra Inc. - Overview
• Exhibit 161: Syantra Inc. - Product / Service
• Exhibit 162: Syantra Inc. - Key offerings
• 12.16 Thermo Fisher Scientific Inc.
• Exhibit 163: Thermo Fisher Scientific Inc. - Overview
• Exhibit 164: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 165: Thermo Fisher Scientific Inc. - Key news
• Exhibit 166: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 167: Thermo Fisher Scientific Inc. - Segment focus
• 12.17 Vijaya Diagnostic Centre Ltd.
• Exhibit 168: Vijaya Diagnostic Centre Ltd. - Overview
• Exhibit 169: Vijaya Diagnostic Centre Ltd. - Business segments
• Exhibit 170: Vijaya Diagnostic Centre Ltd. - Key offerings
• Exhibit 171: Vijaya Diagnostic Centre Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 172: Inclusions checklist
• Exhibit 173: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 174: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 175: Research methodology
• Exhibit 176: Validation techniques employed for market sizing
• Exhibit 177: Information sources
• 13.5 List of abbreviations
• Exhibit 178: List of abbreviations